In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and ...

The American Diabetes Association is advising doctors and patients not to use compounded GLP-1s due to uncertainty about their content, safety, ...

Earlier at ADA, Lilly reported phase 2 results with its once-daily oral GLP-1 agonist orforglipron, which achieved a weight reduction of almost 15% at 24 weeks, potentially giving Lilly the option ...

and at ADA the drugmaker also reported mid-stage results with its oral candidate orforglipron, a non-peptide GLP-1 agonist. The study – published in the New England Journal of Medicine ...

The new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 medications" Sabrina Weiss is the Editorial Assistant of PEOPLE's food ...

Medscape Medical News, June 25, 2024 ADA 2024 GLP-1 Kidney Benefits Seen With or Without SGLT2 Inhibitors Larger studies are needed because of the low numbers of patients on SGLT2 inhibitors in ...

TUESDAY, Nov. 26, 2024 (HealthDay News) -- The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm.

Taking a GLP-1 Medication? Here's Tips to Holiday Eating By Robin Foster HealthDay Reporter SATURDAY, Nov. 23, 2024 (HealthDay News) -- So, you have managed to shed 30 pounds with the help of one ...